1-119925511-C-T

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_024408.4(NOTCH2):​c.4305G>A​(p.Arg1435Arg) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0122 in 1,614,144 control chromosomes in the GnomAD database, including 1,174 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.016 ( 111 hom., cov: 32)
Exomes 𝑓: 0.012 ( 1063 hom. )

Consequence

NOTCH2
NM_024408.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -0.569

Publications

4 publications found
Variant links:
Genes affected
NOTCH2 (HGNC:7882): (notch receptor 2) This gene encodes a member of the Notch family. Members of this Type 1 transmembrane protein family share structural characteristics including an extracellular domain consisting of multiple epidermal growth factor-like (EGF) repeats, and an intracellular domain consisting of multiple, different domain types. Notch family members play a role in a variety of developmental processes by controlling cell fate decisions. The Notch signaling network is an evolutionarily conserved intercellular signaling pathway which regulates interactions between physically adjacent cells. In Drosophilia, notch interaction with its cell-bound ligands (delta, serrate) establishes an intercellular signaling pathway that plays a key role in development. Homologues of the notch-ligands have also been identified in human, but precise interactions between these ligands and the human notch homologues remain to be determined. This protein is cleaved in the trans-Golgi network, and presented on the cell surface as a heterodimer. This protein functions as a receptor for membrane bound ligands, and may play a role in vascular, renal and hepatic development. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jan 2011]
NOTCH2 Gene-Disease associations (from GenCC):
  • acroosteolysis dominant type
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, G2P, Labcorp Genetics (formerly Invitae)
  • Alagille syndrome due to a NOTCH2 point mutation
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • Alagille syndrome
    Inheritance: AD Classification: MODERATE Submitted by: Illumina

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.72).
BP6
Variant 1-119925511-C-T is Benign according to our data. Variant chr1-119925511-C-T is described in ClinVar as Benign. ClinVar VariationId is 195907.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.569 with no splicing effect.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.0987 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NOTCH2NM_024408.4 linkc.4305G>A p.Arg1435Arg synonymous_variant Exon 25 of 34 ENST00000256646.7 NP_077719.2 Q04721Q6IQ50Q9UFD5

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NOTCH2ENST00000256646.7 linkc.4305G>A p.Arg1435Arg synonymous_variant Exon 25 of 34 1 NM_024408.4 ENSP00000256646.2 Q04721

Frequencies

GnomAD3 genomes
AF:
0.0156
AC:
2370
AN:
152138
Hom.:
112
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00270
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0938
Gnomad ASJ
AF:
0.00835
Gnomad EAS
AF:
0.00347
Gnomad SAS
AF:
0.106
Gnomad FIN
AF:
0.0141
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00112
Gnomad OTH
AF:
0.0192
GnomAD2 exomes
AF:
0.0342
AC:
8604
AN:
251302
AF XY:
0.0348
show subpopulations
Gnomad AFR exome
AF:
0.00209
Gnomad AMR exome
AF:
0.132
Gnomad ASJ exome
AF:
0.00774
Gnomad EAS exome
AF:
0.000761
Gnomad FIN exome
AF:
0.0139
Gnomad NFE exome
AF:
0.00160
Gnomad OTH exome
AF:
0.0240
GnomAD4 exome
AF:
0.0119
AC:
17395
AN:
1461888
Hom.:
1063
Cov.:
33
AF XY:
0.0142
AC XY:
10338
AN XY:
727246
show subpopulations
African (AFR)
AF:
0.00185
AC:
62
AN:
33480
American (AMR)
AF:
0.128
AC:
5715
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00826
AC:
216
AN:
26136
East Asian (EAS)
AF:
0.00144
AC:
57
AN:
39700
South Asian (SAS)
AF:
0.107
AC:
9194
AN:
86258
European-Finnish (FIN)
AF:
0.0123
AC:
658
AN:
53414
Middle Eastern (MID)
AF:
0.00347
AC:
20
AN:
5768
European-Non Finnish (NFE)
AF:
0.000613
AC:
682
AN:
1112012
Other (OTH)
AF:
0.0131
AC:
791
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.477
Heterozygous variant carriers
0
1446
2891
4337
5782
7228
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
210
420
630
840
1050
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0156
AC:
2370
AN:
152256
Hom.:
111
Cov.:
32
AF XY:
0.0200
AC XY:
1488
AN XY:
74454
show subpopulations
African (AFR)
AF:
0.00270
AC:
112
AN:
41540
American (AMR)
AF:
0.0937
AC:
1433
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.00835
AC:
29
AN:
3472
East Asian (EAS)
AF:
0.00347
AC:
18
AN:
5180
South Asian (SAS)
AF:
0.106
AC:
512
AN:
4814
European-Finnish (FIN)
AF:
0.0141
AC:
150
AN:
10618
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00112
AC:
76
AN:
68024
Other (OTH)
AF:
0.0190
AC:
40
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
111
221
332
442
553
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
32
64
96
128
160
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00448
Hom.:
13
Bravo
AF:
0.0200
Asia WGS
AF:
0.0560
AC:
194
AN:
3478
EpiCase
AF:
0.000927
EpiControl
AF:
0.00124

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
Mar 11, 2015
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
Jul 14, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Hajdu-Cheney syndrome Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.72
CADD
Benign
5.1
DANN
Benign
0.57
PhyloP100
-0.57
Mutation Taster
=97/3
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs6692009; hg19: chr1-120468134; COSMIC: COSV56689953; COSMIC: COSV56689953; API